• Symbol Lookup



Free Annual Reports From Top Companies Around the Globe: Earnings season is here - Invest like you mean it!

Ariad Pharmaceuticals (ARIA) down on public offering

Tuesday,12 February,2013

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares faded 1% to $19.60. The company on Jan. 23 commenced an underwritten public offering of shares of its common stock. Share volume was 2.6 million, rapidly catching up on an all-day average of 2.8 million



copyright 1998 - 2014 BayStreet.ca Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com